Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells

Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.

[1]  R. Sharan,et al.  Expander: from expression microarrays to networks and functions , 2010, Nature Protocols.

[2]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[3]  Philippe Grandjean,et al.  Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. , 2012, ALTEX.

[4]  L. Smirnova,et al.  Metabolomics in toxicology and preclinical research. , 2013, ALTEX.

[5]  H. Schlüter,et al.  Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells , 2012, PloS one.

[6]  Marcel Leist,et al.  Food for thought ... considerations and guidelines for basic test method descriptions in toxicology. , 2010, ALTEX.

[7]  Tanja Waldmann,et al.  Extensive Transcriptional Regulation of Chromatin Modifiers during Human Neurodevelopment , 2012, PloS one.

[8]  Christian Beste,et al.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. , 2012, Neurotoxicology.

[9]  Thomas Hartung,et al.  The dawning of a new age of toxicology. , 2008, ALTEX.

[10]  Marcel Leist,et al.  Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Marcel Leist,et al.  Evaluation of Developmental Toxicants and Signaling Pathways in a Functional Test Based on the Migration of Human Neural Crest Cells , 2012, Environmental health perspectives.

[12]  M. Tomishima,et al.  Converting human pluripotent stem cells to neural tissue and neurons to model neurodegeneration. , 2011, Methods in molecular biology.

[13]  Melvin E. Andersen,et al.  New directions in toxicity testing. , 2011, Annual review of public health.

[14]  Jeanette Wiltse,et al.  Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin—Developmental Effects of Valproic Acid , 2005, Critical reviews in toxicology.

[15]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[16]  G. B. Gori,et al.  Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[17]  Hedi Peterson,et al.  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach , 2012, Archives of Toxicology.

[18]  Tanja Waldmann,et al.  Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. , 2010, ALTEX.

[19]  Jeroen L A Pennings,et al.  Time-response evaluation by transcriptomics of methylmercury effects on neural differentiation of murine embryonic stem cells. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  Gordon K. Smyth,et al.  Use of within-array replicate spots for assessing differential expression in microarray experiments , 2005, Bioinform..

[21]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[22]  Y. Benjamini,et al.  Adaptive linear step-up procedures that control the false discovery rate , 2006 .

[23]  M. Sztajnkrycer.  Valproic Acid Toxicity: Overview and Management , 2002, Journal of toxicology. Clinical toxicology.

[24]  G. B. Gori,et al.  Scientifically unfounded precaution drives European Commission's recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. , 2013, Toxicon : official journal of the International Society on Toxinology.

[25]  K. Meganathan,et al.  Current status of human pluripotent stem cell based in vitro toxicity tests. , 2013, Frontiers in bioscience.

[26]  Peter Rodgers,et al.  Constructing Area-Proportional Venn and Euler Diagrams with Three Circles , 2005 .

[27]  H M Bolt,et al.  Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate. , 2003, Annual review of pharmacology and toxicology.

[28]  Harvey J Clewell,et al.  Can case study approaches speed implementation of the NRC report: "toxicity testing in the 21st century: a vision and a strategy?". , 2011, ALTEX.

[29]  R. Sharan,et al.  Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. , 2003, Genome research.

[30]  W. Koh,et al.  Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing , 2011, Cell Death and Differentiation.

[31]  Marcel Leist,et al.  GFAP‐independent inflammatory competence and trophic functions of astrocytes generated from murine embryonic stem cells , 2012, Glia.

[32]  Giorgia Pallocca,et al.  miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing , 2013, Cell Biology and Toxicology.

[33]  J. Dopazo,et al.  A function-centric approach to the biological interpretation of microarray time-series. , 2006, Genome informatics. International Conference on Genome Informatics.

[34]  Kim Kultima,et al.  Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[36]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[37]  Flora M. Haaijer-Ruskamp,et al.  Post-Approval Safety Issues with Innovative Drugs: A European Cohort Study , 2013, Drug Safety.

[38]  Melvin E. Andersen,et al.  Temporal concordance between apical and transcriptional points of departure for chemical risk assessment. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[40]  Dorit Merhof,et al.  Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants , 2013, Archives of Toxicology.

[41]  Jeroen L A Pennings,et al.  Transcriptomic concentration-response evaluation of valproic acid, cyproconazole, and hexaconazole in the neural embryonic stem cell test (ESTn). , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  David A. Orlando,et al.  Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes , 2013, Cell.

[43]  Karl-Heinz Krause,et al.  The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. , 2008, ALTEX.

[44]  Tanja Waldmann,et al.  Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. , 2012, Human molecular genetics.

[45]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[46]  K. Meganathan,et al.  A tanscriptomics study to elucidate the toxicological mechanism of methylmercury chloride in a human stem cell based in vitro test. , 2012, Current medicinal chemistry.

[47]  Russell S. Thomas,et al.  Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[48]  Marcel Leist,et al.  Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.